APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. - Wikidata - awgldk - TriplyDB

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

http://www.wikidata.org/entity/Q33423191

about

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging.Sex differences in cognitive impairment and Alzheimer's disease.APOE epsilon4 and the cognitive genetics of multiple sclerosis.Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife.Neurocognitive phenotypes and genetic dissection of disorders of brain and behavior.Challenges of High-resolution Diffusion Imaging of the Human Medial Temporal Lobe in Alzheimer Disease Mapping the Alzheimer's brain with connectomics.Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old.Neuroimaging measures as endophenotypes in Alzheimer's disease HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults.Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE ɛ4 allele.A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.Brain network local interconnectivity loss in aging APOE-4 allele carriers Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.History of sexual assault is associated with greater declines in executive functioning in older adults with APOE epsilon4.Alzheimer risk variant CLU and brain function during aging.Apolipoprotein E acts at pre-synaptic sites...among others Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks.Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.SHIP2 and its involvement in various diseases.Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.Apolipoprotein E in Alzheimer's disease and other neurological disorders.Genetic variations underlying self-reported physical functioning: a review.Lack of association between apolipoprotein E genotypes and cognitive performance in the non-demented elderly.HFE H63D, C282Y and AGTR1 A1166C polymorphisms and brain white matter lesions in the aging brain.Aging and a genetic KIBRA polymorphism interactively affect feedback- and observation-based probabilistic classification learning.Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.The effect of chicken extract on ERK/CREB signaling is ApoE isoform-dependent.Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.Imaging genomics Neuroimaging genetic risk for Alzheimer's disease in preclinical individuals: From candidate genes to polygenic approaches

P2860

Q30476347-B86807ED-CAC3-498D-901A-C78DE1E8058C Q30498720-14CF1123-5F36-4E33-AC5B-76A7EEFBDAA2 Q31122548-B6FF2D62-6F76-4634-9516-EFA304991B06 Q33864547-BEFAD864-C650-4067-B0AF-A8ED664D6A2E Q33871703-88372339-A9E6-4DEB-AAFD-D5B3496C3295 Q33931093-20624FFF-E1FC-4F9C-A4AA-DDAFEBADFCAD Q34009035-70F2D0E8-17DD-4366-AD87-EC52B6F74B90 Q34096462-CF86DB7A-BF77-4EAA-873F-35D09A501269 Q34145777-BBA84C7B-2DB8-405B-B133-2BCB3EB5429C Q34174901-33CA3992-97E3-4E2F-9AC4-279F7E0C6E93 Q34429393-588937E6-B539-4884-BE9C-36838703EEF5 Q34587672-8C80D6AE-95A9-4971-B124-BA73AFDA78D8 Q34924165-AE4BC312-0D2E-4FCA-A6D0-7D44EFB7ABD9 Q35001010-54AD127B-B500-4372-AEEA-FA00AD2777B9 Q35043633-97EF3E06-7636-4547-82BE-E7A36BF5F27E Q35200025-E87DAB7B-063A-430B-9302-2454A5B66FC3 Q35570776-4775FD5B-29E1-4F9E-BEBD-E9927F570499 Q35651340-2DEAA036-F382-4A93-BDAA-8BA880D50E91 Q35677207-F785107A-FC15-4D20-A2FE-2A76E330B515 Q35825830-5759919A-75D8-4698-9E0F-C4DB9342A751 Q36340266-7EF008DE-F214-4753-9F0F-5452DE4ABE8C Q36368439-B1510F4D-1958-4D23-A4F7-49468AA186C7 Q36457047-314CB026-DB10-4C10-987A-44012C77AFDE Q36574825-14A14538-FCB4-4431-854B-F6A91EC88A9A Q36775693-329EE3A3-5777-4DF6-95BF-69DFF8BD5511 Q37019930-5E7D762D-012F-4586-9D2F-A057C090EB67 Q37265703-DD64020B-22D2-433A-834B-391EC6A8B2F3 Q37763949-85A90D45-F3D1-4C5B-B610-684FAB7A3FA7 Q37772498-A9FD157F-D50F-473B-989A-EEB20C8EA876 Q37846932-3C4D4F24-9877-440F-AA4C-E2BEB1FCE406 Q38267213-86AC93D9-A205-4A1A-A3FF-FA2C6C2B63F5 Q44229873-17F377ED-63DF-41F2-82A9-CD063EB52ED5 Q46471786-B40936B9-D632-4397-A5F8-0835CCA81C96 Q47794527-846F5C39-5D96-4882-BDA3-CC53A265434A Q48387166-E9C92A60-13A3-4AC8-86BA-67D32B7E695D Q54333794-60D2732B-9248-46BB-BE52-4CB0152E982D Q55252662-4878988E-811E-4ACE-8A27-C1E42EFACD2C Q57268588-D217F00E-F6F7-445F-8243-5C294F2210E2 Q57513294-17C99D44-0E8A-423B-A423-D4E7BBCAA54C

P2860

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

http://www.wikidata.org/entity/Q33423191

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@ast

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@en

type

label

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@ast

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@en

prefLabel

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@ast

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@en

P1433

Q33423191-7634C908-8D6A-47FC-B5C3-B90A19176B44

P1476

Q33423191-1F77FC13-461A-4A5A-8272-1DA1E2328759

P2093

Q33423191-13095273-8E0C-4BCF-AD1B-1E6A428EB39D

P2860

Q33423191-0093A9A6-079C-4D8E-A059-94D3E050B0FE

Q33423191-01F1C338-D5C9-4373-BD7E-48DDFD813A70

Q33423191-034B0B90-344A-4DA4-802B-E09BF09EC97E

Q33423191-036BA29F-A6D8-478C-8B06-8916544CEB9B

Q33423191-03E7CBF8-FAF6-417F-8489-F39289CA1801

Q33423191-085FDAD5-D469-439F-8EB6-661A8302E14E

Q33423191-09F0AD4D-A97D-4983-818F-E0D261413A62

Q33423191-0D39262C-4776-496A-B422-B93E62F8BAF3

Q33423191-0DDE8B3A-1A27-44B7-9867-5A97A97730A3

Q33423191-0DE7C4EE-E330-48C1-8539-2887202BA581

P304

Q33423191-B537077A-E6E7-487D-97ED-380912E138E7

P31

Q33423191-053C3515-8C70-4C28-8930-55A926B90D14

P356

Q33423191-40DAC6EB-5EDD-4A0B-85E9-A34DC9694CDF

P478

Q33423191-2420DF34-AECE-4E6F-B7DB-9C6C593E3CA5

P50

Q33423191-61FDC30A-3226-4F9F-AA80-D1DC0E4D1EAF

P577

Q33423191-D4646F5B-F3F1-4609-A950-F3CA7FCE3841

P5875

Q33423191-D79C74E3-9708-47E8-9C3E-4D5611E17002

P698

Q33423191-EC239895-FCF5-4749-AF9D-E1883141390F

P921

Q33423191-2E3734C1-19C4-4FCC-8D5D-35F487B4B3A6

Q33423191-AF6258B5-0994-4D6D-B568-FE7FBF4ACC07

P932

Q33423191-8F0335BA-8E74-4085-A39E-79BC2EDFC853

P356

ANNUREV.CLINPSY.032408.153625

P1433

Annual Review of Clinical Psychology

P1476

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.

@en

P2093

Alison Burggren

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

Impact of APOE in mild cognitive impairment

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.

Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.

Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials.

P304

343-362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1146/ANNUREV.CLINPSY.032408.153625

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Susan Y Bookheimer

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24239583

http://www.w3.org/2001/XMLSchema#string

P698

19327032

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

neurophysiology

P932

3118550

http://www.w3.org/2001/XMLSchema#string